Osteoporosis is characterized by a reduction in bone mass or bone mineral density and an increase in fracture risk. As it runs a silent course before presenting with a fracture, the importance of screening especially of risk groups for timely diagnosis and treatment, cannot be overemphasized. Often in developing countries, where access to labs and devices like DXA may be limited, onsite high-volume screening can contribute significantly in diagnosing Osteoporosis cases and contribute towards reduction in morbidity and economic burden due to development of fractures. Though DXA is the gold standard for Osteoporosis diagnosis, recently calcaneal quantitative ultrasound is emerging as a convenient, portable, low cost and radiation free device for in-clinic or onsite screening. Therefore, the differences in parameter interpretation and evaluation, along with relative advantages and disadvantages of using calcaneal QUS over DXA should be well understood before making an informed choice.
INTRODUCTION
Osteoporosis is a disease characterized by low bone mass (bone mineral density-BMD), decreased quality of bone tissue, and increased risk of fracture. [1] The loss in bone density usually continues silently over many years and a fracture may often be the first clinical manifestation usually of advanced disease by that time.
The common Osteoporotic fractures sites include the hip, spine, wrist, and shoulder. [1, 2] Osteopenia refers to decreased bone mineral density (BMD) as compared to normal peak density, but not low enough to significantly increase fracture risk and be considered as Osteoporosis, however it is a risk factor for Osteoporosis. [1] A single cause of Osteoporosis is not established therefore risk factor identification often helps in selecting screening groups to facilitate timely diagnosis. (Table 1) . [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Over 200 million people worldwide, and approximately 30% of all postmenopausal women have Osteoporosis in the United States and in Europe. [13] In India more than 50 million people are either osteoporotic (T-score lower than-2.5) or have low bone mass (T-score between-1.0 and-2.5), and studies indicate that Osteoporosis and Osteopenia or low bone mass may occur at a relatively younger age in Indian population. [14] Screening has an important place in early diagnosis, care and treatment of Osteoporosis.
However, for mass screening or camps, cost and portability of equipment are realistic challenges and limitations. Though Dual-energy X-ray Absorptiometry (DXA or DEXA) remains the gold standard of diagnosis of Osteoporosis, the calcaneal Quantitative Ultrasound (QUS) has been increasingly used in screening camps due to it lower cost, easy transportation and convenience. Therefore, it becomes pertinent to understand how the calcaneal ultrasound compares to the standard DEXA, and what should be its rational and scientific place for measuring bone mineral density (BMD) for the screening and diagnosis of Osteopenia and Osteoporosis.
Table1. Risk factor identification for Osteoporosis screening
Risk Details 1 Age [3]  90% hip fractures occur in people aged ≥50 years. (independent risk factor)  Bone mineral density reduces with age. 2 Female gender [4]  Post-menopausal women are more susceptible to bone loss than men due to reduced estrogen hormone which is important in bone formation.  Women are more likely to sustain an osteoporotic fracture than men with a 40-50% lifetime risk in women, compared to 13-22% in men  Peak bone mass reduced by late menarche.  Premature menopause, especially before the age of 45, is a strong determinant of bone loss and increased risk of fracture [1]  Hysterectomy, with removal of ovaries, increases the risk for Osteoporosis 3 Ethnicity [5]  Osteoporosis is more common in Caucasian and Asian populations  Lower incidence of Osteoporosis and hip fractures in black than in white people 4 Family history [6]  Parental history of fracture (especially hip fracture) is associated with increased risk of fracture (independent of BMD) 5 Past fracture history [7]  A previous fracture increases the risk of any fracture by 86%,  Double risk (1.86 times) of a second fracture 6 Systemic comorbidities and conditions [8]  Some systemic conditions constitute secondary risk factors that directly or indirectly affect bone remodeling, mobility and balance, and increased risk of falling and sustaining a fracture  Like Asthma, Crohn's or celiac disease, Rheumatoid arthritis, Hematological disorders or Malignancies, Hypogonadal states, Endocrine disorders like Cushing's syndrome, Hyperparathyroidism, Diabetes and Chronic Renal Failure. 7 Drugs [9]  Some drugs directly weaken bone or increase fracture risk due to fall or trauma.  Like Corticosteroids, Immunosuppressant (calcineurin inhibitors), L-Thyroxine, Progesterone treatment, Aromatase inhibitors, Certain Antipsychotics, Antiepileptics, Lithium, Methotrexate, Heparin, Antacids and Proton Pump Inhibitors 8 Smoking [10, 11]  Associated with lower BMD, reduced body weight, earlier menopause, increased metabolic breakdown of exogenous estrogen in women.  BMD 2% lower in smokers than in non-smokers for each 10-year increase in age (6% at age 80 years)  Cigarette smoking is independent risk factor for hip fracture 9 Physical
Inactivity [12]  Physical loading and mechanical stress increase BMD  Certain forms of exercise may retard bone loss.  Epidemiological relationship exists between physical inactivity in elderly and the risk of hip and vertebral fracture.
SCREENING

AND DIAGNOSING
OSTEOPOROSIS -CALCANEAL QUS OR DXA
Dual-energy X-ray absorptiometry (DXA, previously DEXA) measures bone mineral density (BMD). Two X-ray beams, with different energy levels, are aimed at the patient's bones (hip and lumbar spine) and the bone mineral density (BMD) is determined from the absorption of each beam by bone after soft tissue absorption is subtracted.
[15] Dualenergy X-ray absorptiometry is the most and thoroughly studied bone density measurement technology and is the gold standard for measuring BMD and diagnosing Osteoporosis.
Bone densities are expressed as T score or Z score. [16] T score expresses BMD in comparison to a young adult of the same gender with peak BMD. A normal T score is ≥ -1.0, low bone density (Osteopenia) is between -1.0 and -2.5, and Osteoporosis is ≤ -2.5. Z score expresses BMD in comparison to the average BMD of a male or female of their age and weight. Severe or established Osteoporosis refers to a T-score more than -2.5 standard deviations below the young adult female reference mean in the presence of one or more fragility fractures.
Quantitative ultrasound (QUS) has recently emerged as a convenient and popular screening tool for Osteoporosis, because it is portable, easier to handle, lower in cost and does not emit ionizing radiation, especially in developing countries where dual-X-ray absorptiometry devices are less accessible to the general population. [17] QUS employs high frequency sound waves with an emission and receiver probe, to determine bone quality, bone microarchitecture and mechanical parameters by studying speed (Speed of Sound -SOS) and attenuation (Broadband Ultrasonic Attenuation-BUA) of ultrasonic waves. Sophisticated devices use additional QUS indices like eBMD (Estimated Bone Mineral Density) which can be calculated from the SOS and BUA. 18 Longitudinal transmission is more often used, and the preferred, most researched and recognized bone segment measured is the calcaneus as it consists of 95% trabecular bone and has two lateral surfaces to facilitate the movement of ultrasound through it.
In the classification of low bone density using DXA, T-score with cut-off points of ≤-1.0 SD for Osteopenia and ≤-2.5 SD for Osteoporosis are used, however, simply applying the DXA cutoffs in QUS measurement can significantly underestimate the true prevalence of Osteoporosis. This was seen in a Korean study (Hologic Sahara QUS device -eBMD) where applicable T-scores for women and men were -2.25 and -1.85, respectively as compared to Tscore of -2.5, the WHO threshold for Osteoporosis. [19] Another device (Osteometer DTUone) has T score cut offs of -1.45 and -2.10 for BUA and SOS. [20] Reference ranges maybe affected by ethnicity (Caucasian reference BMD range is higher than Asian) and gender. In India and Asia, the light weight Furano CM-200 QUS using SOS parameter is commonly used in Osteoporosis screening camps.
The optimal T-score threshold for Osteoporosis diagnosis in QUS was calculated in eight studies where the value varied between -1 and -2.6, with a DXA T-score of -0.9 to -3.3 with one study proposing a T-score threshold as low as -3.65. [21] In most of the studies the QUS T score cut off was either higher (average -2.2+/-0.8) or equal to DXA cut off which correlates with other studies above.
Therefore, the QUS and DXA measurements should not be compared with each other using the same T-score criteria, because of different bone properties measured and different reference populations. A good predictive relationship between hip bone mineral density, as estimated by calcaneal QUS, and direct DXA measurement has been seen, however this correlation decreases for lumbar spine. [22, 23] In patients with Osteoporosis determined by calcaneal QUS or DXA in a Brazilian study, complementing with X-ray was suggested for predicting vertebral fracture. [24] Based on the population data, investigators have found that -1.455 for the right QUS T score and -1.48 for the left QUS T score achieved adequate screening parameters to identify Osteoporosis. [25] Cutoff scores produced a sensitivity of 41% and a specificity of 86.6% for the right QUS T score and a sensitivity of 51.3% and a specificity of 83.3% for the left QUS T score. With a higher QUS T score cut-off of -1.25, sensitivity was higher at 80.4% with a specificity of 59.7% as seen in a study from China. [26] A meta-analysis of 25 studies to assess the accuracy of quantitative ultrasonography compared with DXA in identifying patients with Osteoporosis, various quantitative ultrasonography index parameter cutoffs were used, and the results varied widely in sensitivity and specificity for identifying individuals with a T-score of -2.5 or less on DXA. No quantitative ultrasonography cutoff existed at which sensitivity and specificity were both high. [27] Using the WHO cutoff value for the definition of osteoporosis based on the t-score of ≤ -2.5 the sensitivity and specificity of DXA were seen to be 88.2% 62.5%. [28] Also, QUS cannot be used for diagnostic classification or staging of Osteoporosis, and it is not clinically useful for monitoring the effects of therapy. [29] Physiologically, calcaneal bone tissue undergoes remodeling much more slowly than central bone (spine and hip). Since bone mineral content changes at different rates in different sites of the body, QUS which evaluates a single site will not be as accurate as a more composite evaluation by DXA therefore early osteoporotic changes may not be captured as effectively by QUS as they would be by DXA scan. [30] Analysis has shown, women diagnosed by QUS are four times more likely to have a fracture in the following year than women screened with DEXA. [31] 
CONCLUSION
Table2. Comparative advantages and disadvantages of DXA and Calcaneal QUS
DXA
Calcaneal QUS Most studied, gold standard and first line screening method recommended by standard guidelines [30] [31] [32] Suggested as alternative screening method if access to DXA is limited Done at multiple siteslike hip, and spine Single site -Calcaneum (heel) Standardized T score cut offs for low bone mass and Osteoporosis QUS T score cut offs usually greater than DXA cut offs and are specific for the particular device. (DXA cut offs cannot be applied to QUS) Can be used for diagnosis and monitoring response to therapy Useful only for diagnosis Can be used for diagnostic classification and disease staging.
Should not be used for diagnostic classification and disease staging. Can pick up early disease May not pick up early osteoporotic changes. Difficult to transport device, requires skill in usage. Not conducive for camps and high-volume onsite screening Convenient and easy to use and transport. Suitable for camps and high-volume onsite screening High cost Low cost Exposure to ionizing radiationnot advised during pregnancy No exposure to ionizing radiation
